News

Focus on occupier experience sees cureoscity’s reach grow by over 1400% in a single year

Occupier experience and property management platform Cureoscity, an independent business powered by Grosvenor Hill Ventures, Savills proptech investment subsidiary, has marked its first year since acquisition. The 30 strong, UK based team has now implemented live functionality in over 1,000 individual destinations, primarily in the office sector. Today, Cureoscity technologies are used to improve place performance and engagement across a combined 175 million square feet, up from just 12 million square feet a year ago.  

Founded in 2018, Cureoscity provide a digital platform that connects and enhances customers’ experiences and engagement with their built environment, through web portal and mobile application functionality. Landlords and their property managers benefit from improved relationships, as well as data led insights.  

Cureoscity has implemented digital layer solutions live on assets under the management of leading managing agents, investor and developer clients. Recent notable mobilisations include London Bridge City, The Minster Building and 25 Cabot Square.    

Chris Coleman-Brown, CEO of Cureoscity, says: “Our focus is to allow individuals to have simpler, smarter and more connected engagement with their built environments.  Maximising place performance, by enabling a more connected approach and greater engagement between Occupiers, Managing Agents and Owners of real estate, has never been more important to ensure effective places for all.” Aimee Rootes, COO of Cureoscity, commented: “The last year has seen us make significant improvements to our product capabilities, as a direct result of feedback and evolving requirements from the individual asset teams we work with. As a result of our improved offer and capabilities, we have been able to mobilise entire portfolios of buildings, standardising and evolving legacy systems with an approach that still allows for asset individuality and place personality.”  

For further information, please contact: 

Margaux De Paepe, Cureoscity press office Tel: +44 (0) 7773 666317